Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Cited In for PubMed (Select 19522823)

1.

Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics.

Her YF, Maher LJ 3rd.

Int J Endocrinol. 2015;2015:296167. doi: 10.1155/2015/296167. Epub 2015 Jul 29. Review.

2.

Role of miR-101 in pheochromocytoma patients with SDHD mutation.

Zong L, Meng L, Shi R.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1545-54. eCollection 2015.

3.

Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.

Fishbein L, Khare S, Wubbenhorst B, DeSloover D, D'Andrea K, Merrill S, Cho NW, Greenberg RA, Else T, Montone K, LiVolsi V, Fraker D, Daber R, Cohen DL, Nathanson KL.

Nat Commun. 2015 Jan 21;6:6140. doi: 10.1038/ncomms7140.

4.

Alternative splicing isoform in succinate dehydrogenase complex, subunit C causes downregulation of succinate-coenzyme Q oxidoreductase activity in mitochondria.

Satoh N, Yokoyama C, Itamura N, Miyajima-Nakano Y, Hisatomi H.

Oncol Lett. 2015 Jan;9(1):330-334. Epub 2014 Nov 11.

5.

Pheochromocytoma in a Twelve-Year-Old Girl with SDHB-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome.

Graham D, Gooch M, Ye Z, Richer E, Chishti A, Reilly E, D'Orazio J.

Case Rep Genet. 2014;2014:273423. doi: 10.1155/2014/273423. Epub 2014 Aug 19.

6.

Management and follow up of extra-adrenal phaeochromocytoma.

Barski D.

Cent European J Urol. 2014;67(2):156-61. doi: 10.5173/ceju.2014.02.art8. Epub 2014 Jun 23. Review.

7.

ZNF367 inhibits cancer progression and is targeted by miR-195.

Jain M, Zhang L, Boufraqech M, Liu-Chittenden Y, Bussey K, Demeure MJ, Wu X, Su L, Pacak K, Stratakis CA, Kebebew E.

PLoS One. 2014 Jul 21;9(7):e101423. doi: 10.1371/journal.pone.0101423. eCollection 2014.

8.

BRCA1 induces major energetic metabolism reprogramming in breast cancer cells.

Privat M, Radosevic-Robin N, Aubel C, Cayre A, Penault-Llorca F, Marceau G, Sapin V, Bignon YJ, Morvan D.

PLoS One. 2014 Jul 10;9(7):e102438. doi: 10.1371/journal.pone.0102438. eCollection 2014.

9.

Paragangliomas/Pheochromocytomas: clinically oriented genetic testing.

Martins R, Bugalho MJ.

Int J Endocrinol. 2014;2014:794187. doi: 10.1155/2014/794187. Epub 2014 May 12. Review.

10.

Pheochromocytoma and paraganglioma syndromes: genetics and management update.

Lefebvre M, Foulkes WD.

Curr Oncol. 2014 Feb;21(1):e8-e17. doi: 10.3747/co.21.1579.

11.

Succinate dehydrogenase B subunit immunohistochemical expression predicts aggressiveness in well differentiated neuroendocrine tumors of the ileum.

Milione M, Pusceddu S, Gasparini P, Melotti F, Maisonneuve P, Mazzaferro V, de Braud FG, Pelosi G.

Cancers (Basel). 2012 Aug 16;4(3):808-20. doi: 10.3390/cancers4030808.

12.

Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors.

Belinsky MG, Rink L, von Mehren M.

Front Oncol. 2013 May 17;3:117. doi: 10.3389/fonc.2013.00117. eCollection 2013.

13.

Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.

Pantaleo MA, Astolfi A, Urbini M, Nannini M, Paterini P, Indio V, Saponara M, Formica S, Ceccarelli C, Casadio R, Rossi G, Bertolini F, Santini D, Pirini MG, Fiorentino M, Basso U, Biasco G; GIST Study Group.

Eur J Hum Genet. 2014 Jan;22(1):32-9. doi: 10.1038/ejhg.2013.80. Epub 2013 Apr 24.

14.

Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms.

Miettinen M, Sarlomo-Rikala M, McCue P, Czapiewski P, Langfort R, Waloszczyk P, Wazny K, Biernat W, Lasota J, Wang Z.

Appl Immunohistochem Mol Morphol. 2014 Jan;22(1):31-6. doi: 10.1097/PAI.0b013e31828bfdd3.

15.

Relevance of mitochondrial genetics and metabolism in cancer development.

Gasparre G, Porcelli AM, Lenaz G, Romeo G.

Cold Spring Harb Perspect Biol. 2013 Feb 1;5(2). pii: a011411. doi: 10.1101/cshperspect.a011411. Review.

16.

Paraganglioma with unusual presentation in parotid gland: A diagnostic dilemma in fine needle aspiration.

Vora AA, Lai CK, Rao JY, Apple SK, Moatamed NA.

Cytojournal. 2012;9:26. doi: 10.4103/1742-6413.105119. Epub 2012 Dec 27.

17.

Targeting cancer metabolism.

Teicher BA, Linehan WM, Helman LJ.

Clin Cancer Res. 2012 Oct 15;18(20):5537-45. doi: 10.1158/1078-0432.CCR-12-2587.

18.

Paragangliomas and paraganglioma syndromes.

Boedeker CC.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc03. doi: 10.3205/cto000076. Epub 2012 Apr 26.

19.

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Fishbein L, Nathanson KL.

Cancer Genet. 2012 Jan-Feb;205(1-2):1-11. doi: 10.1016/j.cancergen.2012.01.009. Review.

20.

Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?

Xekouki P, Pacak K, Almeida M, Wassif CA, Rustin P, Nesterova M, de la Luz Sierra M, Matro J, Ball E, Azevedo M, Horvath A, Lyssikatos C, Quezado M, Patronas N, Ferrando B, Pasini B, Lytras A, Tolis G, Stratakis CA.

J Clin Endocrinol Metab. 2012 Mar;97(3):E357-66. doi: 10.1210/jc.2011-1179. Epub 2011 Dec 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk